• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    ImmunoGen, Inc. (IMGN)

    -NasdaqGS
    7.63 Up 1.43(23.06%) Jan 30, 4:00PM EST
    |After Hours : 7.58 Down 0.05 (0.66%) Jan 30, 7:59PM EST
    Add to Portfolio
    Prev Close:6.20
    Open:6.75
    Bid:N/A
    Ask:7.74 x 300
    1y Target Est:8.02
    Beta:2.12
    Earnings Date:Apr 23 - Apr 27 (Est.)
    Day's Range:6.68 - 8.45
    52wk Range:5.34 - 17.80
    Volume:11,652,271
    Avg Vol (3m):1,780,710
    Market Cap:655.68M
    P/E (ttm):N/A
    EPS (ttm):-0.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMGN

    Comparison

    Symbol% ChgMkt Cap
    IMGNUp 23.06%655.68M
    PFEDown 1.82%196.90B
    RHHBYDown 1.79%N/A
    SGENDown 1.08%3.86B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.53
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.71
    Quarterly EPS Est (Mar-15) :-0.22
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback